Zhejiang Benli Technology Co (301065) Fair Value & Analysis
Basic Materials · CN · Market cap 2.0B CNY
Fair value as of: Jun 24, 2026
Analysis
Zhejiang Benli Technology Co (301065) currently trades at ¥18.85, while our model-based Fair Value estimate is ¥13.19 — implying the stock looks roughly 30.0% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, 2,4-Dichlorofluorobenzene, and Methyl 3-methoxyacrylate; and Ethyl N,N-dimethylaminoacrylate, 2,6-Dichlorofluorobenzene, and 3-(2-Ethylene Glycol Methyl Ether)-2-Methyl -4-Methanesulfonyl benzoic acid. The company was founded in 2011 and is based in Linhai, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Zhejiang Benli Technology Co (301065) undervalued?
What is the fair value of 301065?
What is the quality score of 301065?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.